Lindner, A.K.; Furlan, T.; Orme, J.J.; Tulchiner, G.; Staudacher, N.; D’Andrea, D.; Culig, Z.; Pichler, R.
HUS1 as a Potential Therapeutic Target in Urothelial Cancer. J. Clin. Med. 2022, 11, 2208.
https://doi.org/10.3390/jcm11082208
AMA Style
Lindner AK, Furlan T, Orme JJ, Tulchiner G, Staudacher N, D’Andrea D, Culig Z, Pichler R.
HUS1 as a Potential Therapeutic Target in Urothelial Cancer. Journal of Clinical Medicine. 2022; 11(8):2208.
https://doi.org/10.3390/jcm11082208
Chicago/Turabian Style
Lindner, Andrea Katharina, Tobias Furlan, Jacob J. Orme, Gennadi Tulchiner, Nina Staudacher, David D’Andrea, Zoran Culig, and Renate Pichler.
2022. "HUS1 as a Potential Therapeutic Target in Urothelial Cancer" Journal of Clinical Medicine 11, no. 8: 2208.
https://doi.org/10.3390/jcm11082208
APA Style
Lindner, A. K., Furlan, T., Orme, J. J., Tulchiner, G., Staudacher, N., D’Andrea, D., Culig, Z., & Pichler, R.
(2022). HUS1 as a Potential Therapeutic Target in Urothelial Cancer. Journal of Clinical Medicine, 11(8), 2208.
https://doi.org/10.3390/jcm11082208